Radiopharmaceuticals and Tracers

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with ...

Vizamyl, flutemetamol, FDA, GE

The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) a...

flurpiridaz f18 comparison

Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT). Nevertheless, widespread clinical use of PET MPI has been limited by the currently avai...

ICB Intl. Inc., (ICBI), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for...
Navidea Biopharmaceuticals Inc. held an update meeting with the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
John M. Tomich Ekaterina Dadachova Clinica Study Radiation Nontoxic Molecules
Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and effective storage lockers for harmful isotopes that...
April 1, 2014 — A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
Based on Philips’ proprietary digital photon counting technology, the Vereos PET/CT is the first PET/CT system in the industry to use...
The U.S. Food and Drug Administration (FDA) designated the Society of Nuclear Medicine and Molecular Imaging's (SNMMI's) ...
Vizamyl (flutemetamol F 18 injection) is a radiopharmaceutical tracer for use with positron emission tomography (PET) imaging of...

Articles

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...
An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with ...
Vizamyl, flutemetamol, FDA, GE
The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission...
Myocardial perfusion imaging (MPI) with positron emission tomography (PET) has been shown to be superior to single photon emission computed tomography (SPECT...

Video Center

The 24th Annual Interdisciplinary Breast Center Conference (NCoBC 2014), sponsored by the National...
4 weeks 10 hours ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
5 weeks 2 days ago
Vienna is to the European Congress of Radiology what Chicago is to RSNA. This year the ECR...
5 weeks 6 days ago
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and technologies include...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
Lydia Liao spectral mammography
During this webinar, Lydia Liao,  M.D., Ph.D., M.P.H., presented an overview of contrast-enhanced spectral mammography technology and shared cases where SenoBright has...

Comparison Charts

Sorry there is no data available